| http://www.w3.org/ns/prov#value | - As Dr. Ross and Dr. Soreth just pointed out, the action items from the Public Health Action Plan included efforts to stimulate the development of priority products to treat antimicrobial resistance, a streamlining of the regulatory process, and to identify ways, financial and other incentives, to promote the development of new antimicrobial agents, and we applaud these efforts.
|
